Headlands Research, a leading multinational network of clinical trial sites, announces the acquisition of CMRCenter (CMRC), a high-performing clinical research site in San Juan, Puerto Rico. The deal expands Headlands’ footprint to 22 sites across the United States, Canada, and Puerto Rico, giving biopharma sponsors a turnkey, single-contract gateway to one of the largest Hispanic patient populations under FDA oversight and accelerating enrollment for vaccine, CNS, and specialty studies. “CMRC’s proven performance in CNS, vaccine, and specialty trials, combined with its deep ties to Puerto Rico’s diverse, FDA-regulated patient community, gives sponsors a seamless, single-contract path to high-quality enrollment in a priority market,” said Kyle Burtnett, CEO of Headlands Research.
Read the full article: Headlands Research Enters the Caribbean with Acquisition of CMRCenter //
Source: https://www.prnewswire.com/news-releases/headlands-research-enters-the-caribbean-with-acquisition-of-cmrcenter-302496233.html